China Gansu Network July 9th According to the Gansu Daily Report (New Gansu Gansu Daily Reporter Yi Xiuping) Recently, the Provincial People's Hospital innovatively integrated the Da Vinci surgical robot and the intraoperative radiotherapy system to perform surgery on two patients. At the same time, more than ten minutes of intraoperative radiation therapy to kill potential residual tumor cells. This initiative not only greatly reduces the potential risk of tumor recurrence, but also saves time and reduces the dose of radiation for subsequent routine radiotherapy.
Intraoperative radiotherapy refers to a single large dose of precise irradiation of the tumor bed area or the junction of the tumor and the normal tissue after surgical removal of the tumor, which can effectively kill the remaining residual tumor cells in a single operation during the operation, so as to retain as much as possible. The purpose of organ function. In 2019, the Provincial People's Hospital introduced an intraoperative radiotherapy system that represents a new trend in radiotherapy, which is very effective in killing residual tumor cells in the tumor bed, and does not harm the surrounding normal organs and tissues.
The two patients who underwent surgery had extrahepatic cholangiocarcinoma and gastric cancer. During the operation, a general surgeon Ma Yuntao operated the Da Vinci surgical robot to accurately remove the tumor and involved the organ. Subsequently, Ma Yuntao and the radiotherapy center doctor Cai Hongyu jointly consulted to determine the potential risk of tumor recurrence after surgery, using intraoperative radiotherapy. The device illuminates these areas.
The Department of Breast Diseases of the Provincial People's Hospital also cooperated with the radiotherapy center to expand the scope of treatment with intraoperative radiotherapy, which is an invisible scalpel, and successfully completed breast-conserving surgery for breast cancer. According to reports, intraoperative radiotherapy as an emerging tumor treatment technology, suitable for most solid tumors, has been widely used in many clinical cancer treatment areas, becoming another weapon for clinical anti-tumor.xx